Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis by Vanja Zeremski, Siegfried Kropf, Michael Koehler, Michael Koehler, Niklas Gebauer, Ellen D. McPhail, Thomas Habermann, Francesca Schieppati, Dimitrios Mougiakakos

Get full text

P1152: DEPTH OF METABOLIC RESPONSE AT INTERIM PET AND SURVIVAL OUTCOMES AMONG PATIENTS WITH PRIMARY REFRACTORY OR EARLY RELAPSING DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) by Allison Bock, Raphael Mwangi, Fatemeh Ataei, Matthew Thorpe, Matthew Maurer, Josh Pritchett, Jacob Shreve, Jonas Paludo, James Cerhan, Arushi Khurana, Thomas Witzig, Thomas Habermann, Yucai Wang, Grzegorz S. Nowakowski, Jason Young

Get full text

P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS by Steven Hwang, Jacqueline Wang, Zizhong Tian, Xinyue Qi, Yi Jiang, Shijia Zhang, Richard C. Godby, Sameer Parikh, Wei Ding, Paul Hampel, Javier Munoz, Jonas Paludo, Saad Kenderian, Eli Muchtar, Mazie Tsang, Talal Hilal, Jose Leis, Gita Thanarajasingam, David Inwards, Grzegorz S. Nowakowski, Stephen Ansell, Thomas Habermann, Thomas Witzig, Neil Kay, Shouhao Zhou, Yucai Wang

Get full text